Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome
about
Diagnosis and management of functional symptoms in inflammatory bowel disease in remissionDiagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysisFood allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivityBiomarkers of Environmental Enteric Dysfunction Among Children in Rural Bangladesh.A predictive model combining fecal calgranulin B and fecal occult blood tests can improve the diagnosis of colorectal cancer.Validating biomarkers of treatable mechanisms in irritable bowel syndromeRecent advances in the diagnosis of irritable bowel syndrome.Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases.Host response to Clostridium difficile infection: Diagnostics and detection.Association of enteric parasitic infections with intestinal inflammation and permeability in asymptomatic infants of São Tomé Island.Proteomics and irritable bowel syndrome.Inflammatory Bowel Disease in Childhood and Adolescence.Evolution of the Diagnosis of Functional Gut Disorders: Is an Objective Positive Diagnostic Approach Within Reach?Fecal calprotectin in patients with suspected small bowel disease--a selection tool for small bowel capsule endoscopy?Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.Dissecting Lewis score under the light of fecal calprotectin; an analysis of correlation of score components with calprotectin levels in capsule endoscopyFaecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy.Identification of matrix metalloproteinase-2 and -9 activities within the intestinal mucosa of dogs with chronic enteropathies.Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study
P2860
Q26768264-AE901D4B-5FD9-4845-A8CF-C0E2A3D5EF88Q28066449-0D6E42BA-6D91-43AF-9B5F-E571D7B175F9Q28087731-8AD0F9D0-9D9D-407F-B41B-6B4902DEBC33Q30491088-A3E85744-C504-4CC1-AAD5-F9C53B2827B5Q34134711-92FB2834-3C39-485A-9A2C-77D0EE584BA6Q34577283-621A37D0-BDF1-4F7A-B267-43CEE0238D57Q38545062-494294D4-7047-41EF-904A-F2345AD5B103Q38774391-44D95193-A38F-4114-9464-1FD3950378ABQ38969987-BDC602F8-24D5-4AFB-9B33-21A732792FAAQ39018458-4F846D93-A02D-4B72-8E55-2128D5FEDC15Q39232397-2EF80598-9FD4-4966-A5D2-3BD94BBB428DQ39361742-70F9B2B7-3EAF-4A53-92D1-AE5F3340DF2AQ39746914-71B39EAB-8ED6-4E78-89D3-3FD6354F91C6Q41578341-798EF1A9-71BF-4536-9768-D22328E19987Q41928544-70CCEAF3-BA7D-4593-8546-EA22F7624EC1Q41978455-45DA76D8-63F7-4AA8-B472-DF7A3988851FQ50944124-CBAE579A-DCA2-4D46-9F2B-D7866B811F8FQ52660146-05FE5CC3-5121-4939-B1C9-CCA247CE2CEAQ57284254-F2325BCA-799D-4255-800B-522E44F60BC1
P2860
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome
@en
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome.
@nl
type
label
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome
@en
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome.
@nl
prefLabel
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome
@en
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome.
@nl
P2860
P921
P356
P1476
Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome
@en
P2093
Dirk Foell
Jason Musci
P2860
P304
P356
10.3748/WJG.V20.I2.363
P407
P50
P577
2014-01-01T00:00:00Z